Thrivent Financial for Lutherans’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.31M Sell
28,039
-74,318
-73% -$8.58M 0.01% 1197
2026
Q1
$12.2M Buy
102,357
+14,861
+17% +$1.95M 0.02% 576
2025
Q4
$11.9M Buy
87,496
+62,846
+255% +$9.04M 0.02% 608
2025
Q3
$3.64M Sell
24,650
-23,020
-48% -$3.19M 0.01% 991
2025
Q2
$6.17M Buy
47,670
+37,701
+378% +$4.57M 0.01% 737
2025
Q1
$1.19M Sell
9,969
-59,719
-86% -$7.4M ﹤0.01% 1603
2024
Q4
$8.09M Sell
69,688
-1,410
-2% -$178K 0.02% 735
2024
Q3
$9.6M Buy
71,098
+19,816
+39% +$2.65M 0.02% 690
2024
Q2
$6.96M Buy
51,282
+41,010
+399% +$5.58M 0.01% 779
2024
Q1
$1.33M Sell
10,272
-193
-2% -$23.3K ﹤0.01% 1721
2023
Q4
$1.2M Sell
10,465
-100
-0.9% -$9.98K ﹤0.01% 1725
2023
Q3
$962K Sell
10,565
-63
-0.6% -$6.5K ﹤0.01% 1767
2023
Q2
$1.2M Buy
10,628
+2,558
+32% +$271K ﹤0.01% 1683
2023
Q1
$845K Buy
8,070
+20
+0.2% +$2.09K ﹤0.01% 1876
2022
Q4
$890K Buy
8,050
+33
+0.4% +$3.46K ﹤0.01% 1798
2022
Q3
$700K Buy
8,017
+78
+1% +$7.09K ﹤0.01% 1898
2022
Q2
$621K Sell
7,939
-28,554
-78% -$2.36M ﹤0.01% 1991
2022
Q1
$3.11M Buy
36,493
+19
+0.1% +$1.82K 0.01% 1075
2021
Q4
$4.37M Sell
36,474
-1,063
-3% -$132K 0.01% 950
2021
Q3
$4.64M Sell
37,537
-140
-0.4% -$18K 0.01% 921
2021
Q2
$4.52M Buy
37,677
+27
+0.1% +$3.08K 0.01% 974
2021
Q1
$3.96M Sell
37,650
-1,526
-4% -$155K 0.01% 1014
2020
Q4
$3.99M Buy
39,176
+30,987
+378% +$2.91M 0.01% 946
2020
Q3
$689K Sell
8,189
-132
-2% -$10.3K ﹤0.01% 1804
2020
Q2
$541K Sell
8,321
-24,387
-75% -$1.61M ﹤0.01% 1873
2020
Q1
$2.13M Sell
32,708
-164,669
-83% -$13M 0.01% 924
2019
Q4
$15.6M Buy
197,377
+17,802
+10% +$1.39M 0.04% 447
2019
Q3
$14.3M Buy
179,575
+447
+0.2% +$35.1K 0.04% 409
2019
Q2
$15M Buy
179,128
+15,516
+9% +$1.24M 0.05% 405
2019
Q1
$12.9M Buy
163,612
+155,748
+1,981% +$11.4M 0.04% 416
2018
Q4
$525K Buy
7,864
+138
+2% +$9.55K ﹤0.01% 1529
2018
Q3
$617K Buy
7,726
+171
+2% +$12.8K ﹤0.01% 1574
2018
Q2
$509K Buy
7,555
+60
+0.8% +$4.36K ﹤0.01% 1675
2018
Q1
$577K Buy
7,495
+182
+2% +$13.5K ﹤0.01% 1571
2017
Q4
$499K Sell
7,313
-103,845
-93% -$6.89M ﹤0.01% 1691
2017
Q3
$6.96M Sell
111,158
-7,091
-6% -$424K 0.02% 538
2017
Q2
$6.55M Buy
118,249
+45,689
+63% +$2.38M 0.03% 505
2017
Q1
$3.64M Sell
72,560
-75,690
-51% -$3.69M 0.02% 677
2016
Q4
$7.34M Buy
148,250
+320
+0.2% +$16.2K 0.03% 476
2016
Q3
$7.76M Sell
147,930
-236,600
-62% -$11.6M 0.04% 459
2016
Q2
$17.2M Sell
384,530
-109,430
-22% -$4.75M 0.08% 242
2016
Q1
$20.2M Buy
493,960
+451,840
+1,073% +$16.6M 0.1% 196
2015
Q4
$1.54M Buy
+42,120
New +$1.52M 0.01% 930

Other funds holding XYL

Thrivent Financial for Lutherans's XYL Position: Q2 2026 in Review

Thrivent Financial for Lutherans reduced its Xylem (XYL) stake by 73% in Q2 2026, selling an estimated $8.58M and leaving 28,039 shares worth $3.31M. The position accounts for 0.01% of the portfolio, ranked #1197.

Thrivent Financial for Lutherans first reported a position in XYL in Q4 2015 and has held it in 43 quarters since. The position peaked at $20.2M in Q1 2016. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Thrivent Financial for Lutherans held 28,039 shares of Xylem worth $3.31M as of Q2 2026.
  • Thrivent Financial for Lutherans sold 74,318 Xylem shares in Q2 2026, an estimated $8.58M.
  • Xylem made up 0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #1197 holding.
  • Thrivent Financial for Lutherans first reported a position in Xylem in Q4 2015 and has held it in 43 quarters since.
  • Thrivent Financial for Lutherans's Xylem position peaked at $20.2M in Q1 2016.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.